| Inhibition of breast cancer metastasis by presurgical treatment with an oral matrix metalloproteinase inhibitor: a preclinical proof-of-principle study A Winer, M Janosky, B Harrison, J Zhong, D Moussai, P Siyah, ... Molecular cancer therapeutics 15 (10), 2370-2377, 2016 | 36 | 2016 |
| c-Myc inhibitor 10074-G5 induces murine and human hematopoietic stem and progenitor cell expansion and HDR modulator Rad51 expression M Aksoz, E Albayrak, GS Aslan, RD Turan, LY Alyazici, P Siyah, ... Current cancer drug targets 19 (6), 479-494, 2019 | 30 | 2019 |
| Development of Small Molecule MEIS Inhibitors that modulate HSC activity RD Turan, E Albayrak, M Uslu, P Siyah, LY Alyazici, BM Kalkan, GS Aslan, ... Scientific reports 10 (1), 7994, 2020 | 26 | 2020 |
| New nimesulide derivatives with amide/sulfonamide moieties: Selective COX-2 inhibition and antitumor effects T Güngör, A Ozleyen, YB Yılmaz, P Siyah, M Ay, S Durdağı, TB Tumer European Journal of Medicinal Chemistry 221, 113566, 2021 | 23 | 2021 |
| Discovery of potential PD-L1 small molecule inhibitors as novel cancer therapeutics using machine learning-based QSAR models: A virtual drug repurposing study P Siyah, S Durdagi, B Aksoydan Biophysical Journal 122 (3), 144a, 2023 | 2 | 2023 |
| Identification of first-in-class plasmodium OTU inhibitors with potent anti-malarial activity P Siyah, S Akgol, S Durdagi, F Kocabas Biochemical Journal 478 (18), 3445-3466, 2021 | 2 | 2021 |
| Modulating Cas9 activity for precision gene editing M Uslu, P Siyah, AJ Harvey, F Kocabaş Progress in Molecular Biology and Translational Science 181, 89-127, 2021 | 2 | 2021 |
| Novel etodolac derivatives as eukaryotic elongation factor 2 kinase (eEF2K) inhibitors for targeted cancer therapy FC Onder, P Siyah, S Durdagi, M Ay, B Ozpolat RSC Medicinal Chemistry 13 (7), 840-849, 2022 | 1 | 2022 |
| Identification of viral OTU-like plasmodium parasite proteases and development of antimalarial DUB inhibitors P Siyah, S Akgol, S Durdagi, F Kocabas Available at SSRN 3773786, 2021 | 1 | 2021 |
| c-Myc inhibition is critical for HSC expansion and Rad51 expression M Aksoz, E Albayrak, GS Aslan, RD Turan, LY Alyazici, P Siyah, ... bioRxiv, 403584, 2018 | 1 | 2018 |
| Identification of novel hematopoeitic small molecules enables ex vivo hematopoietic stem cell expansion F Kocabas, RD Turan, DD Celik, E Albayrak, M Aksoz, EC Tuysuz, ... FEBS JOURNAL 283, 35-35, 2016 | | 2016 |
